<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="133905-2018"
            EDITION="2018060">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-137435-001</RECEPTION_ID>
      <DELETION_DATE>20180704</DELETION_DATE>
      <FORM_LG_LIST>EN </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>60</NO_OJ>
         <DATE_PUB>20180327</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 060-133905</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="EN">http://ted.europa.eu/udl?uri=TED:NOTICE:133905-2018:TEXT:EN:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>EN</LG_ORIG>
         <ISO_COUNTRY VALUE="NO"/>
         <IA_URL_GENERAL>www.ous-hf.no</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33100000">Medical equipments</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="NO">NORGE</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="NO">NORGE</n2016:CA_CE_NUTS>
         <n2016:TENDERER_NUTS CODE="NO">NORGE</n2016:TENDERER_NUTS>
         <VALUES>
            <VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="NOK">6900000.00</VALUE>
         </VALUES>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180326</DS_DATE_DISPATCH>
         <AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="V">Voluntary ex ante transparency notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="V">Contract award without prior publication</PR_PROC>
         <RP_REGULATION CODE="B">European Economic Area (EEA), with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="Z">Not specified</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>03B15</HEADING>
         <INITIATOR>03</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Норвегия</TI_CY>
            <TI_TOWN>Осло</TI_TOWN>
            <TI_TEXT>
               <P>Медицинско оборудване</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Norsko</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Zdravotnické přístroje</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Norge</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Medicinsk udstyr</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Norwegen</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Medizinische Geräte</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Νορβηγία</TI_CY>
            <TI_TOWN>Όσλο</TI_TOWN>
            <TI_TEXT>
               <P>Ιατρικές συσκευές</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>Norway</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Medical equipments</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Noruega</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Equipamiento médico</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Norra</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Meditsiiniseadmed</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Norja</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Lääketieteelliset laitteet</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Norvège</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Équipements médicaux</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Iorua, an</TI_CY>
            <TI_TOWN>Osló</TI_TOWN>
            <TI_TEXT>
               <P>Medical equipments</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Norveška</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Medicinske naprave</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Norvégia</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Orvosi felszerelések</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Norvegia</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Apparecchiature mediche</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Norvegija</TI_CY>
            <TI_TOWN>Oslas</TI_TOWN>
            <TI_TEXT>
               <P>Medicinos įranga</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Norvēģija</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Medicīniskās ierīces</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>in-Norveġja</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Tagħmir mediku</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Noorwegen</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Medische apparatuur</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Norwegia</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Urządzenia medyczne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Noruega</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Equipamento médico</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Norvegia</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Echipamente medicale</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Nórsko</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Zdravotnícke vybavenie</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Norveška</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Medicinska oprema</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Norge</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Medicinsk utrustning</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="EN">Oslo universitetssykehus HF</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <NOTICE_UUID>d8397091-3c2f-4a50-a424-7063c3a078a5</NOTICE_UUID>
      <F15_2014 CATEGORY="ORIGINAL" FORM="F15" LG="EN">
         <DIRECTIVE VALUE="2014/24/EU"/>
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>Oslo universitetssykehus HF</OFFICIALNAME>
               <NATIONALID>993 467 049</NATIONALID>
               <ADDRESS>Postboks 4950 Nydalen</ADDRESS>
               <TOWN>Oslo</TOWN>
               <POSTAL_CODE>0424</POSTAL_CODE>
               <COUNTRY VALUE="NO"/>
               <CONTACT_POINT>Trine Kjellsen</CONTACT_POINT>
               <PHONE>+47 91667242</PHONE>
               <E_MAIL>trikje@ous-hf.no</E_MAIL>
               <n2016:NUTS CODE="NO"/>
               <URL_GENERAL>www.ous-hf.no</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY>
            <CA_TYPE VALUE="BODY_PUBLIC"/>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>75179 AS KLM Avd for medisinsk biokjemi [The Department of Medical Biochemistry], Analysis Machine.</P>
            </TITLE>
            <REFERENCE_NUMBER>75179</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33100000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>A new immunoassay instrument shall be procured for the Hormone Laboratory, Department of Medical Biochemistry, Oslo University Hospital. The new instrument shall have an analytical method for the determination of antibodies against thyroid hormone receptors (TRAS).</P>
            </SHORT_DESCR>
            <VAL_TOTAL CURRENCY="NOK">6900000.00</VAL_TOTAL>
            <NO_LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33100000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="NO"/>
               <MAIN_SITE>
                  <P>Oslo University HF [Oslo University Hospital Health Trust - OUS].</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>A new immunoassay instrument shall be procured for the Hormone Laboratory, Department of Medical Biochemistry, Oslo University Hospital. The new instrument shall have an analytical method for the determination of antibodies against thyroid hormone receptors (TRAS).</P>
                  <P>The procurement will be carried out via ex ante transparency notice.</P>
                  <P>Reasons for the Voluntary ex ante transparency notice:</P>
                  <P>The analysis instrument has some A-requirements that are important for daily operations.</P>
                  <P>— The analysis instrument must be able to analyse both stimulatory and blocking TRAS.</P>
                  <P>— The analysis instrument must be fully automatic (including pipetting of samples and reagents, incubating, washing, reading and dilution of samples).</P>
                  <P>— The analysis instrument must be able to carry out immuno-fluorometric methods (IFMA), i.e. the trace molecule is a fluoridising earth metal or equivalent.</P>
                  <P>— The analysis technique must not be based on biotin and streptavidin marked reagents.</P>
                  <P>— The analysis instrument must be able to read off positive bar code identification and be able to communicate with LIS.</P>
                  <P>— The analysis instrument must be able to analyse &gt;100 samples in each set-up.</P>
                  <P>— The analysis instrument must be able to be used for multiple analyses simultaneously, also from the same sample.</P>
                  <P>— The analysis instrument must be able to analyse standards and make a calibration curve.</P>
                  <P>— The analysis instrument must be able to analyse samples, controls and standards.</P>
                  <P>— The analysis instrument must be able to pipette samples from 13 x 75mm tubes and should be able to use mikrokopper.</P>
                  <P>— The analysis instrument´s computer systems shall be robust, simple to operate and compatible with existing systems in the laboratory.</P>
                  <P>— The analysis instrument must have two-way communication with an external computer system. The laboratory uses the data system LabVantage Medical Suit, from Software Point – LabVantage Group.</P>
                  <P>— The analysis instrument should have a user-friendly statistics programme for registration of controls and calculation of precision and accuracy.</P>
                  <P>It is also important that the analysis instrument has options to:</P>
                  <P>— Programme for calculating concentration based on a standard curve.</P>
                  <P>— The analysis instrument ought to have an interface programme for data transfer of results/checks.</P>
                  <P>— The analysis instrument should be able to discharge waste directly into the drain.</P>
                  <P>— The analysis instrument ought to have detection of fluid level.</P>
                  <P>— The analysis instrument should be able to define durability of all reagents / plates included in the analysis, as well as logging the lot in use.</P>
                  <P>— Any interferences, for example, from bilirubinemia, lipaemia and hemolysis, must be documented for the analysis.</P>
               </SHORT_DESCR>
               <OPTIONS/>
               <OPTIONS_DESCR>
                  <P>Service agreements.</P>
               </OPTIONS_DESCR>
               <NO_EU_PROGR_RELATED/>
               <INFO_ADD>
                  <P>This agreement concerns the purchase of 2 Kryptor plus Compact. For kits and other necessary reagents, see the framework agreement 2018xxxxx00.</P>
                  <P>The framework agreement for kits and other necessary reagents lasts as long as the equipment is in use at Oslo University Hospital or at the trial.</P>
               </INFO_ADD>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <DIRECTIVE_2014_24_EU>
               <PT_AWARD_CONTRACT_WITHOUT_CALL>
                  <D_OUTSIDE_SCOPE/>
                  <D_JUSTIFICATION>
                     <P>The analysis instrument has some A-requirements that are important for daily operations.</P>
                     <P>— The analysis instrument must be able to analyse both stimulatory and blocking TRAS.</P>
                     <P>— The analysis instrument must be fully automatic (including pipetting of samples and reagents, incubating, washing, reading and dilution of samples).</P>
                     <P>— The analysis instrument must be able to carry out immuno-fluorometric methods (IFMA), i.e. the trace molecule is a fluoridising earth metal or equivalent.</P>
                     <P>— The analysis technique must not be based on biotin and streptavidin marked reagents.</P>
                     <P>— The analysis instrument must be able to read off positive bar code identification and be able to communicate with LIS.</P>
                     <P>— The analysis instrument must be able to analyse &gt;100 samples in each set-up.</P>
                     <P>— The analysis instrument must be able to be used for multiple analyses simultaneously, also from the same sample.</P>
                     <P>— The analysis instrument must be able to analyse standards and make a calibration curve.</P>
                     <P>— The analysis instrument must be able to analyse samples, controls and standards.</P>
                     <P>— The analysis instrument must be able to pipette samples from 13 x 75mm tubes and should be able to use microcups.</P>
                     <P>— The analysis instrument´s computer systems shall be robust, simple to operate and compatible with existing systems in the laboratory.</P>
                     <P>— The analysis instrument must have two-way communication with an external computer system. The laboratory uses the data system LabVantage Medical Suit, from Software Point – Labvantage Group.</P>
                     <P>— The analysis instrument should have a user-friendly statistics programme for registration of controls and calculation of precision and accuracy.</P>
                     <P>It is also important that the analysis instrument has options to:</P>
                     <P>— Programme for calculating concentration based on a standard curve.</P>
                     <P>— The analysis instrument ought to have an interface programme for data transfer of results/checks.</P>
                     <P>— The analysis instrument should be able to discharge waste directly into the drain.</P>
                     <P>— The analysis instrument ought to have detection of fluid level.</P>
                     <P>— The analysis instrument should be able to define durability of all reagents / plates included in the analysis, as well as logging the lot in use.</P>
                     <P>— Any interferences, for example, from bilirubinemia, lipaemia and hemolysis, must be documented for the analysis.</P>
                     <P>— This is based on Thermo Fischer Scientific Norge AS being the only supplier that can perform the delivery in accordance with the requirements. The intention notice is pursuant to the public procurement regulations § 21-5. The terms in FOA § 13-4 (2) and 13-1 (5) are deemed to be fulfilled as well as the value of the full service contract for the instrument´s lifetime.</P>
                  </D_JUSTIFICATION>
               </PT_AWARD_CONTRACT_WITHOUT_CALL>
            </DIRECTIVE_2014_24_EU>
            <FRAMEWORK/>
            <CONTRACT_COVERED_GPA/>
         </PROCEDURE>
         <AWARD_CONTRACT ITEM="1">
            <TITLE>
               <P>75179 AS KLM Avd for medisinsk biokjemi [The Department of Medical Biochemistry], Analysis Machine.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-23</DATE_CONCLUSION_CONTRACT>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Thermo Fisher Scientific AS</OFFICIALNAME>
                     <NATIONALID>986400990</NATIONALID>
                     <ADDRESS>Ullernchausseen 52</ADDRESS>
                     <TOWN>Oslo</TOWN>
                     <POSTAL_CODE>0379</POSTAL_CODE>
                     <COUNTRY VALUE="NO"/>
                     <n2016:NUTS CODE="NO"/>
                     <URL>www.thermofisher.com</URL>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="NOK">6900000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <COMPLEMENTARY_INFO>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>Oslo Universitetssykehus HF</OFFICIALNAME>
               <ADDRESS>Sognvanssveien 20</ADDRESS>
               <TOWN>Oslo</TOWN>
               <POSTAL_CODE>0372</POSTAL_CODE>
               <COUNTRY VALUE="NO"/>
               <PHONE>+47 23071580</PHONE>
               <E_MAIL>mtu-anbud@ous-hf.no</E_MAIL>
               <URL>www.ous-hf.no</URL>
            </ADDRESS_REVIEW_BODY>
            <REVIEW_PROCEDURE>
               <P>The waiting period is ten days (due to public holidays, we have added days).</P>
               <P>Deadline for lodging appeals: 9.4.2018 (12:00).</P>
            </REVIEW_PROCEDURE>
            <DATE_DISPATCH_NOTICE>2018-03-26</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F15_2014>
   </FORM_SECTION>
</TED_EXPORT>
